NASDAQ: XTLB
Xtl Biopharmaceuticals Ltd Stock Ownership - Who owns Xtl Biopharmaceuticals?

Insider buying vs selling

Have Xtl Biopharmaceuticals Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when XTLB insiders and whales buy or sell their stock.

XTLB Shareholders

What type of owners hold Xtl Biopharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Joseph Edelman12.83%113,123,680$94.68MInsider
Noked Israel Ltd0.02%198,888$166.47kInstitution
Benzion Weiner0.01%50,000$41.85kInsider
Michael S. Weiss0.00%25,000$20.93kInsider
Ron Bentsur0.00%20,101$16.82kInsider
Rhumbline Advisers0.00%17,261$14.45kInstitution
Morgan Stanley0.00%10,011$8.38kInstitution
William Kessler0.00%5,000$4.19kInsider
Ubs Group Ag0.00%763$638.63Institution

1 of 1

XTLB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XTLB0.03%12.85%
VIVS1.26%98.74%Net SellingNet Selling
CLDI1.45%98.55%Net BuyingNet Selling
MBIO3.84%13.88%Net SellingNet Selling
GTBP3.52%11.34%

Xtl Biopharmaceuticals Stock Ownership FAQ

Who owns Xtl Biopharmaceuticals?

Xtl Biopharmaceuticals (NASDAQ: XTLB) is owned by 0.03% institutional shareholders, 12.85% Xtl Biopharmaceuticals insiders, and 87.13% retail investors. Joseph Edelman is the largest individual Xtl Biopharmaceuticals shareholder, owning 113.12M shares representing 12.83% of the company. Joseph Edelman's Xtl Biopharmaceuticals shares are currently valued at $96.16M.

If you're new to stock investing, here's how to buy Xtl Biopharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.